Present status of digitalis therapy

Therapeutic benefits of digitalis have been questioned in the recent past. Its use in heart failure with sinus rhythm has been given up and replaced by diuretics and vasodilators except in some cases of systolic overload. It is indicated in heart failureee with atrial fibrilation. Verapamil, diltiazem and beta-blockers can be an adjunct to digitals therapy in this situation and obviate the necessity of near-toxicc doses. Its useee in arrbytbmias has also been largely replaced by calcium and beta-blockers. The majority of investigators do not approve its use in eitber acute or chronic ischemic beart